90Y‐IBRITUMOMAB TIUXETAN IN PATIENTS WITH EXTRA‐NODAL MARGINAL ZONE B‐CELL LYMPHOMA OF MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA) – THE ZENO STUDY. (12th June 2019)